Publication | Closed Access
Phase 1 clinical study to assess the safety of a novel drug delivery system providing long‐term topical steroid therapy for chronic rhinosinusitis
16
Citations
22
References
2019
Year
LYR-210 is safe and well-tolerated in ESS-naive CRS patients and leads to sustained symptom improvement in patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1